ACCESSION: MSBNK-SMB_Measured-HSA032P0072002
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 21
COMMENT: RAW_SPEC {'HC7-pos_212': {'bp': 2988.0, 'sum': 10199.0}, 'RA1-pos_219': {'bp': 2901.0, 'sum': 11323.0}, 'RA17-pos_198': {'bp': 2696.0, 'sum': 7155.0}, 'HC15-pos_211': {'bp': 2577.0, 'sum': 9410.0}, 'RA17-pos_210': {'bp': 2374.0, 'sum': 7540.0}, 'QC2-pos_199': {'bp': 2360.0, 'sum': 11729.0}, 'HC10-pos_234': {'bp': 2225.0, 'sum': 8032.0}, 'RA15-pos_221': {'bp': 1986.0, 'sum': 6519.0}, 'QC1-pos_205': {'bp': 1835.0, 'sum': 8103.0}, 'HC18-pos_220': {'bp': 1747.0, 'sum': 6351.0}, 'HC12-pos_215': {'bp': 1712.0, 'sum': 6256.0}, 'HC16-pos_253': {'bp': 1562.0, 'sum': 5287.0}, 'HC22-pos_212': {'bp': 1510.0, 'sum': 4622.0}, 'RA15-pos_234': {'bp': 1371.0, 'sum': 6009.0}, 'HC18-pos_208': {'bp': 1369.0, 'sum': 6038.0}, 'RA18-pos_189': {'bp': 1360.0, 'sum': 5013.0}, 'QC8-pos_215': {'bp': 1074.0, 'sum': 3586.0}, 'HC3-pos_179': {'bp': 964.0, 'sum': 3749.0}, 'QC5-pos_210': {'bp': 895.0, 'sum': 3783.0}, 'RA11-pos_214': {'bp': 824.0, 'sum': 3615.0}, 'RA13-pos_219': {'bp': 783.0, 'sum': 3059.0}}
COMMENT: RETENTION_TIME_STDEV 0.012
COMMENT: PRECURSOR_M/Z_RAW 72.080896
COMMENT: PRECURSOR_M/Z_STDEV 0.000196
COMMENT: PRECURSOR_IN_MS1 mz 72.080869; int 76.691; delta(ppm) 1.812311
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 1.238; C4H9N; [M+H]+; delta(ppm) 1.238153
COMMENT: PROPOSED_MF MS-FINDER 3.806; C4H9N; [M+H]+; delta(ppm) 1.210775
COMMENT: PROPOSED_MF SIRIUS5_Sirius 9.934; C4H9N; [M+H]+; delta(ppm) 1.210775
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H9N; [M+H]+; delta(ppm) 1.210775
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.324; C4H9N; [M+H]+; delta(ppm) 1.210775
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H9N; [M+H]+; delta(ppm) 1.210775
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.750; UJGVUACWGCQEAO-UHFFFAOYSA-N; [M+H]+; CCN1CC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.694; IOXXVNYDGIXMIP-UHFFFAOYSA-N; [M+H]+; CNCC=C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.626; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; C1CCNC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.472; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; CC1(CN1)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.450; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; C1CC(C1)N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.321; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; Pyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.212; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; cyclobutanamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.159; ASVKKRLMJCWVQF-UHFFFAOYSA-N; [M+H]+; 3-buten-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.052; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylaziridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.873; IOXXVNYDGIXMIP-UHFFFAOYSA-N; [M+H]+; N-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.789; UJGVUACWGCQEAO-UHFFFAOYSA-N; [M+H]+; 1-ethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; UJGVUACWGCQEAO-UHFFFAOYSA-N; [M+H]+; 1-ethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.840; IOXXVNYDGIXMIP-UHFFFAOYSA-N; [M+H]+; N-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.796; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.776; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; Pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.755; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; cyclobutanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.343; ASVKKRLMJCWVQF-UHFFFAOYSA-N; [M+H]+; 3-buten-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.773; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.442; CSWPOLMVXVBCSV-UHFFFAOYSA-N; [M+H]+; 2-ethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.251; IGSKHXTUVXSOMB-UHFFFAOYSA-N; [M+H]+; cyclopropylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; QFUSOYKIDBRREL-NSCUHMNNSA-N; [M+H]+; (E)-but-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.180; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; cyclobutanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.177; IOXXVNYDGIXMIP-UHFFFAOYSA-N; [M+H]+; N-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.042; VEBLEROFGPOMPB-UHFFFAOYSA-N; [M+H]+; N-methylcyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.978; VXDHQYLFEYUMFY-UHFFFAOYSA-N; [M+H]+; 2-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.941; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.924; DLBWPRNUXWYLRN-UHFFFAOYSA-N; [M+H]+; 2-methylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.911; HTHMVKNHGOVITA-UHFFFAOYSA-N; [M+H]+; 3-methylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.898; PYTANBUURZFYHD-UHFFFAOYSA-N; [M+H]+; 2-methylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; JDCBWJCUHSVVMN-UHFFFAOYSA-N; [M+H]+; but-3-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.855; VSRXAWSAKJABKW-UHFFFAOYSA-N; [M+H]+; 1-methylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.511; ASVKKRLMJCWVQF-UHFFFAOYSA-N; [M+H]+; but-3-en-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -37.215; RWRDLPDLKQPQOW; [M+H]+; Azolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -66.440; JDCBWJCUHSVVMN; [M+H]+; 3-Buten-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -69.638; IOXXVNYDGIXMIP; [M+H]+; Allylmethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -73.328; QFUSOYKIDBRREL; [M+H]+; Crotylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -78.502; ASVKKRLMJCWVQF; [M+H]+; 3-Buten-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -84.033; UJGVUACWGCQEAO; [M+H]+; 1-ethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -90.907; VXDHQYLFEYUMFY; [M+H]+; Methallylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -91.707; IGSKHXTUVXSOMB; [M+H]+; Cyclopropylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -102.938; VEBLEROFGPOMPB; [M+H]+; Cyclopropyl-methylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -106.447; CSWPOLMVXVBCSV; [M+H]+; Butyleneimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -112.199; KZZKOVLJUKWSKX; [M+H]+; Cyclobutanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.440; PYTANBUURZFYHD; [M+H]+; Cyclopropanamine, 2-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -136.417; VSRXAWSAKJABKW; [M+H]+; Ambcb4021534
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.654; FGRJGEWVJCCOJJ; [M+H]+; 2,2-Dimethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -163.946; HNPYZRNUMNPTAQ; [M+H]+; Dimethyl aziridinium
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.391; RWRDLPDLKQPQOW; [M+H]+; Azolidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -65.051; FGRJGEWVJCCOJJ; [M+H]+; 2,2-Dimethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -68.448; QFUSOYKIDBRREL; [M+H]+; 2-Butenylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -71.273; IOXXVNYDGIXMIP; [M+H]+; Methyl(prop-2-enyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -73.527; RWRDLPDLKQPQOW; [M+H]+; 2,2,3-Trideuteriopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -76.613; UJGVUACWGCQEAO; [M+H]+; 1-Ethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -89.918; VXDHQYLFEYUMFY; [M+H]+; 2-Methylallylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -95.017; CSWPOLMVXVBCSV; [M+H]+; 2-Ethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -107.605; IGSKHXTUVXSOMB; [M+H]+; Cyclopropanemethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -107.777; JDCBWJCUHSVVMN; [M+H]+; 2-Deuteriobut-3-en-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -109.919; ASVKKRLMJCWVQF; [M+H]+; 3-Buten-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.032; FGRJGEWVJCCOJJ; [M+H]+; 2,2-Dimethylaziridine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H10N1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 0.655
MS$FOCUSED_ION: PRECURSOR_M/Z 72.080863
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00dl-9000000000-ea18fb92d5eec45ca53c
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  28.0186076 61.7956 28.018897 24.9120 19.99 0.4654 15 f{C1H2N1}/15.42ppm,p-C3H8
  30.0343449 218.8150 30.034643 20.4100 77.65 0.6242 15 f{C1H4N1}/17.29ppm,p-C3H6
  31.9894970 74.8755 31.989801 23.2576 28.83 0.6474 16 ?
  39.9636566 150.7539 39.963970 14.6383 76.17 0.3434 18 ?
  42.0347072 287.2034 42.035019 19.1033 106.71 0.5349 21 f{C2H4N1}/20.98ppm,p-C2H6
  42.9859380 349.4044 42.986248 17.7733 114.25 0.6780 19 ?
  44.0503575 85.4925 44.050665 23.8591 36.32 0.4656 19 f{C2H6N1}/20.02ppm,p-C2H4
  61.5120136 75.9649 61.512219 25.0845 43.80 0.4597 19 ?
  72.0821079 999.0000 72.082266 18.5760 0.00 1.0000 20 f{C4H10N1}/18.48ppm,p
  75.5155074 126.5656 75.515678 19.1351 54.01 0.8776 19 ?
PK$NUM_PEAK: 10
PK$PEAK: m/z int. rel.int.
  28.018608 61.80 61
  30.034345 218.81 218
  31.989497 74.88 74
  39.963657 150.75 150
  42.034707 287.20 287
  42.985938 349.40 349
  44.050358 85.49 85
  61.512014 75.96 75
  72.082108 999.00 999
  75.515507 126.57 126
//
